Skip to main content
Journal cover image

Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias.

Publication ,  Journal Article
Chouairi, F; Fudim, M; Benak, A; Piccini, JP; Toman, J; Kautzner, J; Ganesh, A; Sramko, M
Published in: ESC Heart Fail
February 2025

AIMS: One treatment option for refractory ventricular arrythmias is stellate ganglion block (SGB). We examined differences in SGB success by patient and arrhythmia characteristics and predictors of successful SGB. METHODS AND RESULTS: This was a multicenter analysis of patients treated for refractory ventricular arrythmias in the Czech Republic and the United States. The primary outcome was absence of ventricular arrythmias at 24 h post SGB. SGB effectiveness was examined according to aetiology of cardiomyopathy, arrhythmia type, laterality of SGB, presence of inotropes, and presence of mechanical circulatory support. Binary logistic regression was used to examine variables associated with the primary outcome. In total there were 117 patients with refractory ventricular arrythmias treated with SGB. Overall, the mean age was 63.5 ± 11.0 years, majority of patients were male (94.0%), White (87.2%), and had an implantable cardioverter defibrillator in situ (70.1%). There were no differences in efficacy of SGB based on aetiology of cardiomyopathy (P = 0.623), arrhythmia type (0.852), laterality of block (P = 0.131), and presence of inotropes (P = 0.083). Multivariable analysis demonstrated that increased age was associated with decreased odds of SGB success (odds ratio: 0.96, confidence interval: 0.92-0.99, P = 0.039) whereas increased left ventricular ejection fraction trended towards increased odds of SGB success (odds ratio: 1.05, confidence interval: 0.995-1.11, P = 0.077). CONCLUSIONS: In this multicentre experience, SGB was similarly effective despite the aetiology of cardiomyopathy, type of arrhythmia, laterality, and inotropic or mechanical support. SGB was less effective for the suppression of ventricular arrythmias at 24 h for the elderly.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

ESC Heart Fail

DOI

EISSN

2055-5822

Publication Date

February 2025

Volume

12

Issue

1

Start / End Page

110 / 117

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Tachycardia, Ventricular
  • Stellate Ganglion
  • Retrospective Studies
  • Recurrence
  • Middle Aged
  • Male
  • Humans
  • Follow-Up Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chouairi, F., Fudim, M., Benak, A., Piccini, J. P., Toman, J., Kautzner, J., … Sramko, M. (2025). Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias. ESC Heart Fail, 12(1), 110–117. https://doi.org/10.1002/ehf2.15072
Chouairi, Fouad, Marat Fudim, Ales Benak, Jonathan P. Piccini, Jakub Toman, Josef Kautzner, Arun Ganesh, and Marek Sramko. “Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias.ESC Heart Fail 12, no. 1 (February 2025): 110–17. https://doi.org/10.1002/ehf2.15072.
Chouairi F, Fudim M, Benak A, Piccini JP, Toman J, Kautzner J, et al. Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias. ESC Heart Fail. 2025 Feb;12(1):110–7.
Chouairi, Fouad, et al. “Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias.ESC Heart Fail, vol. 12, no. 1, Feb. 2025, pp. 110–17. Pubmed, doi:10.1002/ehf2.15072.
Chouairi F, Fudim M, Benak A, Piccini JP, Toman J, Kautzner J, Ganesh A, Sramko M. Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias. ESC Heart Fail. 2025 Feb;12(1):110–117.
Journal cover image

Published In

ESC Heart Fail

DOI

EISSN

2055-5822

Publication Date

February 2025

Volume

12

Issue

1

Start / End Page

110 / 117

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Tachycardia, Ventricular
  • Stellate Ganglion
  • Retrospective Studies
  • Recurrence
  • Middle Aged
  • Male
  • Humans
  • Follow-Up Studies